Print

Endocyte, Inc. Raises $75M, Gains 12% After Cutting Price  
2/4/2011 12:36:43 PM

Feb. 4 (Bloomberg) -- Endocyte Inc., a developer of drugs for ovarian and lung tumors, raised $75 million in its initial public offering after cutting the price twice this week for a total reduction of as much as 60 percent.
//-->